RecruitingNCT05258448

COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)

The Effect of Radiotherapy on the Heart in Loco-regional Advanced NSCLC Patients Treated With Definitive Radiotherapy Measured by Cardiac MR

Sponsor

Odense University Hospital

Enrollment

100 participants

Start Date

Aug 1, 2015

Study Type

OBSERVATIONAL

Conditions

Radiation Toxicity Cardiac Toxicity Lung Cancer Stage II Lung Cancer Stage III Cardiac Disease

Summary

Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Age ≥ 18 Years
Inoperable and histologically/cytologically verified NSCLC.
Planned treatment with curative intent.
Capable of completing study procedures ECG and Cardiac MR.
Able of giving written and informed consent before study procedures are initiated.

Exclusion Criteria3

Vulnerable patients.
Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated.
Claustrophobia.